Byers Eye Institute at Stanford
Palo Alto, California, 94303, United States
NCT Number: NCT01592643
The purpose of this research is to determine if an investigational thin shield over the cornea can safely and effectively reduce or eliminate pain following Post Photorefractive Keratectomy (PRK).
The thin shield is made of silicone. The materials used to make the corneal shield all have a history of use in medical devices, contact lenses, and/or corneal shields and have been used safely in the eye.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94303, United States
See above
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
.
Exclusion criteria
.
The thin shield is made of silicone. The materials used to make the corneal shield all have a history of use in medical devices, contact lenses, and/or corneal shields and have been used safely in the eye.
Other names: Nexis Vision corneal shield
Time frame: Day 30
Time frame: Six months
LogMAR uncorrected visual acuity. Values closer to zero indicate improved vision
Stanford University
Other
Acronym: Nexis-CS0032
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07752680
Comfort, Congenital Abnormalities
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT02313571
Neurologic Manifestations, Pain
Singapore
View Trial DetailsNCT02373696
Neurologic Manifestations, Pain
Singapore
View Trial DetailsNCT06498713
Agnosia, Nervous System Diseases
New Haven, Connecticut, United States
View Trial Details